Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00541_DB00954_nanopub.RAD9nobkXdGk16L-X3J_gGu892wDsfBnttXeNQKQnPESI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00541_DB00954 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00541_DB00954 label "DDI between Vincristine and Dirithromycin - Dirithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Dirithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB00954]" assertion.
- drugbank_resource:DB00541_DB00954 identifier "drugbank_resource:DB00541_DB00954" assertion.
- drugbank_resource:DB00541_DB00954 title "DDI between Vincristine and Dirithromycin - Dirithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Dirithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00541 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB00954 assertion.
- drugbank:DB00954 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB00954 assertion.